Carlyle has acquired Abingworth, according to a news release.

Abingworth, with U.S. offices in Boston and Menlo Park, Calif., is a transatlantic life sciences investment firm. Founded in 1973, the firm reports approximately $2 billion in assets under…
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Carlyle Acquires Abingworth

Peloton Equity has announced it has closed a growth and recapitalization investment in Grenova.

Grenova, based in Richmond, Va., is a manufacturer of green technology for the life sciences industry. Founded in 2014, the company produces waste reduction solution,…
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Peloton Equity, Other Investors Invest in Grenova

Frazier Healthcare Partners has announced the closing of Frazier Life Sciences XI with more than $987 million in capital commitments.

The new fund, which exceeded its target of $800 million, is Frazier Life Sciences’ fourth venture fund focused on biopharmaceuticals.
Continue Reading Frazier Healthcare Partners Closes $987 Million Life Sciences Fund

Broad Sky Partners has acquired Thomas Scientific from The Carlyle Group, according to a news release.

Thomas Scientific, based in Swedesboro, N.J., and founded in 1900, is a provider of supplies to the healthcare, biotech, clinical diagnostics and…
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Broad Sky Acquires Thomas Scientific From The Carlyle Group

Ampersand Capital Partners has announced it has sold portfolio company Adaptas Solutions to IMI.

Adaptas, based in Palmer, Mass., provides components for complex laboratory instruments in the life sciences, diagnostics and lab automation markets.

IMI, formerly Imperial Metal…
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand Capital Sells Adaptas to IMI

Avesi Partners has announced it has invested in Danforth Advisors.

Danforth, based in Waltham, Mass., is a provider of strategic and operational finance and accounting for life science companies. The company states that it has served more than 750…
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Avesi Invests in Danforth Advisors

Frazier Healthcare Partners has announced the closing of its first dedicated public life sciences fund.

Frazier Life Sciences Public Fund is closing on nearly $830 million in capital commitments, which exceeds its target. It is a long-only fund that will…
Continue Reading Frazier Healthcare Closes $830 Million Life Sciences Fund